TRENTON, NJ — Assemblyman Jay Webber, representing District 26, has introduced Assembly Bill No. 2653 in the 221st Legislature session. The legislation aims to impose new restrictions on the use of cadaveric fetal tissue for research purposes. Co-sponsored by Assemblyman Kanitra, Assemblywoman Fantasia, and Assemblyman Inganamort.
Under the proposed legislation, the use of cadaveric fetal tissue derived from elective abortion procedures for research will be prohibited. This includes any research into cosmetic treatments. However, the bill makes exceptions for tissue obtained following a miscarriage or stillbirth, which can still be used for other research purposes. This move aligns with existing prohibitions against the sale or purchase of embryonic or fetal tissue, reinforcing the state and federal stance on these matters.
Furthermore, the bill mandates that healthcare professionals involved in treating infertility must provide patients with comprehensive information to make informed decisions about the disposition of any remaining embryos after treatment. Patients will be required to acknowledge in writing that they have received this information, which will then be included in their medical records.
Assemblyman Webber’s bill underscores a commitment to ethical considerations in medical research, particularly in the sensitive area of fetal tissue research. By distinguishing between the sources of cadaveric fetal tissue, the legislation aims to respect the nuanced ethical landscape while still permitting certain research activities that could lead to medical advancements.